{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:50:37Z","timestamp":1785563437362,"version":"3.56.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Program of Cangzhou City","award":["23244102084"],"award-info":[{"award-number":["23244102084"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Gout represents the most common form of inflammatory arthritis, exerting a substantial impact on patient quality of life and productivity. In recent years, the age distribution of gout has shifted, with an increasing incidence among younger individuals. Accurate statistics regarding the incidence, prevalence, and disability-adjusted life years (DALYs) associated with gout in this population are critical for effective resource allocation in prevention and treatment strategies. In the current study, data from the 2021 Global Burden of Disease (GBD) database were used to analyze the burden of gout among young people aged 15\u201344 years in 204 countries and territories from 1990 to 2021, with projections extending over the next 25 years. Data on prevalence, incidence, and DALYs were collected and stratified by geographical location, gender, and economic development level. Decomposition analysis and predictive modeling were employed to evaluate trends and the impact of critical indicators. In 2021, 8,516,229 young individuals were affected by gout globally, with 1,975,165 new cases and DALYs totaling 283,725 person-years. Since 1990, the age-standardized prevalence rate, age-standardized incidence rate, and age-standardized DALYs rate increased by 10.4%, 9.4%, and 10.2%, respectively, all showing positive correlation with the sociodemographic index (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.319, 0.272, 0.320,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). It is projected that by 2046, global figures in young people will reach approximately 9,229,870 total cases, 2,202,802 new cases, and 307,441 DALYs. Males are anticipated to account for 7,460,349 affected individuals, 1,762,412 new cases, and 245,542 DALYs, whereas females will represent 1,769,521 affected individuals, 440,390 new cases, and 61,899 DALYs. The global disease burden of gout among young people increased significantly from 1990 to 2021, and it is expected to continue rising over the next 25 years. Comprehensive epidemiological data remain essential for guiding gout prevention and management, as well as shaping effective health policies.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0333368","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:40:42Z","timestamp":1761759642000},"page":"e0333368","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Global burden of gout among young people from 1990 to 2021, with projections for 2050: A systematic analysis based on the Global Burden of Disease Study 2021"],"prefix":"10.1371","volume":"20","author":[{"given":"Peipei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3215-1385","authenticated-orcid":true,"given":"Guangya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"pone.0333368.ref001","article-title":"Gout","author":"N Dalbeth","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"pone.0333368.ref002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrrheum.2009.236","article-title":"Update on gout: new therapeutic strategies and options","volume":"6","author":"R Terkeltaub","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"pone.0333368.ref003","article-title":"Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"6","author":"GBD 2021 Gout Collaborators","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"8","key":"pone.0333368.ref004","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"HK Choi","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"pone.0333368.ref005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/acr.25292","article-title":"Unclosing premature mortality gap among patients with gout in the US general population, independent of serum urate and atherosclerotic cardiovascular risk factors","volume":"76","author":"N McCormick","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"pone.0333368.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","volume":"80","author":"C Borghi","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"5","key":"pone.0333368.ref007","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.2022.11390","article-title":"Association between gout flare and subsequent cardiovascular events among patients with gout","volume":"328","author":"E Cipolletta","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"pone.0333368.ref008","article-title":"Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey","volume":"10","author":"AE Hak","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"pone.0333368.ref009","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the united states and decadal trends: The National Health and Nutrition Examination Survey, 2007-2016","volume":"71","author":"M Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"pone.0333368.ref010","doi-asserted-by":"crossref","first-page":"924676","DOI":"10.3389\/fpubh.2022.924676","article-title":"Mapping knowledge structure and global research trends in gout: a bibliometric analysis from 2001 to 2021","volume":"10","author":"P Wen","year":"2022","journal-title":"Front Public Health"},{"key":"pone.0333368.ref011","first-page":"41","article-title":"Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: a systematic review","volume":"34","author":"A Rezapour","year":"2020","journal-title":"Med J Islam Repub Iran"},{"issue":"3","key":"pone.0333368.ref012","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"SL Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"10258","key":"pone.0333368.ref013","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"pone.0333368.ref014","article-title":"Pearson\u2019s or Spearman\u2019s correlation coefficients","volume":"138","author":"AH Pripp","year":"2018","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"8","key":"pone.0333368.ref015","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population","volume":"31","author":"KL Wallace","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"pone.0333368.ref016","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/S0102-311X2011000200018","article-title":"Hyperuricemia and associated factors: a cross-sectional study of Japanese-Brazilians","volume":"27","author":"J Poletto","year":"2011","journal-title":"Cad Saude Publica"},{"issue":"1","key":"pone.0333368.ref017","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12891-017-1465-9","article-title":"Sex differences in gout characteristics: tailoring care for women and men","volume":"18","author":"LR Harrold","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"9417","key":"pone.0333368.ref018","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: a prospective study","volume":"363","author":"HK Choi","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"pone.0333368.ref019","first-page":"2186","article-title":"Female gout: clinical and laboratory features","volume":"32","author":"AWS De Souza","year":"2005","journal-title":"J Rheumatol"},{"issue":"10","key":"pone.0333368.ref020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/ard.2006.051649","article-title":"Sex differences in gout epidemiology: evaluation and treatment","volume":"65","author":"LR Harrold","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"pone.0333368.ref021","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003191","article-title":"Filling gaps in female gout: a cross-sectional study of comorbidities in 192 037 hospitalised patients","volume":"9","author":"E Rodr\u00edguez-Sosa","year":"2023","journal-title":"RMD Open"},{"issue":"6","key":"pone.0333368.ref022","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/ard.2011.200523","article-title":"Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study","volume":"71","author":"GG Teng","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"pone.0333368.ref023","doi-asserted-by":"crossref","first-page":"802856","DOI":"10.3389\/fmed.2022.802856","article-title":"Incident gout: risk of death and cause-specific mortality in Western Sweden: a prospective, controlled inception cohort study","volume":"9","author":"M Dehlin","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"pone.0333368.ref024","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40273-015-0288-5","article-title":"A Systematic review of the economic and humanistic burden of gout","volume":"33","author":"GE Shields","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"pone.0333368.ref025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27421","article-title":"Estimation of primary prevention of gout in men through modification of obesity and other key lifestyle factors","volume":"3","author":"N McCormick","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pone.0333368.ref026","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1038\/s41598-025-86090-z","article-title":"A comprehensive analysis of trends in the burden of gout in China and globally from 1990 to 2021","volume":"15","author":"S Xie","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0333368.ref027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0522-8","article-title":"Epidemiology and management of gout in Taiwan: a nationwide population study","volume":"17","author":"C-F Kuo","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"pone.0333368.ref028","article-title":"Epidemiology of gout - Global burden of disease research from 1990 to 2019 and future trend predictions","volume":"15","author":"T Han","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"11","key":"pone.0333368.ref029","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.3390\/nu12113401","article-title":"Ultraprocessed food: addictive, toxic, and ready for regulation","volume":"12","author":"RH Lustig","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"pone.0333368.ref030","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3945\/ajcn.116.135004","article-title":"Ultraprocessed food consumption and risk of overweight and obesity: the University of Navarra Follow-Up (SUN) cohort study","volume":"104","author":"D Mendon\u00e7a R de","year":"2016","journal-title":"Am J Clin Nutr"},{"issue":"10258","key":"pone.0333368.ref031","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(20)31404-5","article-title":"Five insights from the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Viewpoint Collaborators","year":"2020","journal-title":"Lancet"},{"key":"pone.0333368.ref032","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex421","article-title":"Education and non-pharmacological approaches for gout","volume":"57","author":"A Abhishek","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"pone.0333368.ref033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26804","article-title":"Racial and sex disparities in gout prevalence among US Adults","volume":"5","author":"N McCormick","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9","key":"pone.0333368.ref034","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3949\/ccjm.83a.15133","article-title":"Gout and African Americans: reducing disparities","volume":"83","author":"B Kumar","year":"2016","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"pone.0333368.ref035","first-page":"34","article-title":"Influence of various purines on uric acid metabolism","volume":"19","author":"N Z\u00f6llner","year":"1973","journal-title":"Bibl Nutr Dieta"},{"issue":"11","key":"pone.0333368.ref036","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"HK Choi","year":"2004","journal-title":"N Engl J Med"},{"issue":"7","key":"pone.0333368.ref037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0328543","article-title":"The disease burden of gout in Asian countries and regions from 1990 to 2021, risk factors and forecast analysis: a systematic study of Asian disease burden in 2021","volume":"20","author":"F Yang","year":"2025","journal-title":"PLoS One"},{"key":"pone.0333368.ref038","doi-asserted-by":"crossref","first-page":"1613801","DOI":"10.3389\/fpubh.2025.1613801","article-title":"Systematic analysis of gout burden among young adults in China from 1990 to 2021: findings from the global burden of disease study 2021","volume":"13","author":"Y Zhong","year":"2025","journal-title":"Front Public Health"},{"issue":"4","key":"pone.0333368.ref039","first-page":"647","article-title":"Epidemiology of hyperuricemia and gout in Japan","volume":"66","author":"M Hakoda","year":"2008","journal-title":"Nihon Rinsho"},{"issue":"4","key":"pone.0333368.ref040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1524-4733.2007.00173.x","article-title":"The impact of gout on work absence and productivity","volume":"10","author":"NL Kleinman","year":"2007","journal-title":"Value Health"},{"issue":"1","key":"pone.0333368.ref041","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/kes211","article-title":"Gout and its comorbidities: implications for therapy","volume":"52","author":"LK Stamp","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"pone.0333368.ref042","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"JA Singh","year":"2020","journal-title":"Semin Arthritis Rheum"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:40:49Z","timestamp":1761759649000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333368"}},"subtitle":[],"editor":[{"given":"Wesam","family":"Gouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333368","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}